You are about leaving the Roche Diagram website now.


Advancing Patient Access to Next-Generation Sequencing for Cancer in Asia Pacific

NGS Whitepaper Feature Image - Future of Healthcare

Next Generation Sequencing (NGS) has emerged as a potential game-changer in cancer care, as the Asia-Pacific (APAC) region continues to witness increasing burden of cancer, imposing clinical, societal, and economic burden.

In particular, NGS enables the delivery of personalised cancer care through tumour profiling, and multiple studies in APAC have shown the real-world impact on improving patient outcomes through shortening time to results, identifying more patients for matched therapies and clinical trials and decreasing diagnosis costs compared to current practice.

Building on the efforts of APACMed’s previous publication “Unlocking the Value of Quality Next-Generation Sequencing in APAC”, this paper presents an overview of the status of access to NGS-based cancer care in APAC and actions required to improve access, including a first-of-its-kind value assessment framework for NGS tailored to the regional context.

NGS White Paper Infographic 1 - Future of Healthcare

Read the whitepaper here.

You May Also Like

12 May 2023

How labs can help to reduce the burden of women’s diseases

The essential role of laboratories in removing stigmas surrounding STIs so that women can be better positioned in their own fertility journey.

Read More
12 May 2023

The Battle to Eliminate the World’s Only Preventable Cancer

Cervical cancer is preventable but lack of awareness about the disease and access to screening have often been the main obstacle. We talk to experts from Indonesia and Thailand on…

Read More